Shepherd Neame Limited (AQU:SHEP)

Verve Therapeutics Revenue

Shepherd Neame had revenue of 85.04M GBP in the half year ending December 28, 2024, a decrease of -0.34%. This brings the company's revenue in the last twelve months to 168.31M, down -0.97% year-over-year. In the fiscal year ending June 29, 2024, Shepherd Neame had annual revenue of 172.29M with 3.62% growth.

• Revenue (ttm): 168.31M
• Revenue Growth: -0.97%
• P/S Ratio: 0.43
• Revenue / Employee: 92.28K
• Employees: 1,824
• Market Cap: 73.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 29, 2024	172.29M	6.02M	3.62%
Jun 24, 2023	166.27M	14.73M	9.72%
Jun 25, 2022	151.54M	64.65M	74.41%
Jun 26, 2021	86.88M	-31.32M	-26.50%
Jun 27, 2020	118.21M	-27.59M	-18.93%